Did Mylan Win By Losing Perrigo?

Mylan’s (MYL) failed hostile takeout bid for rival generic drug maker Perrigo (PRGO) is hitting the two stocks in drastically different ways. Mylan, the supposed loser in this months-long fight, surged more than 13% to a recent $49 as investors rejoiced at the elimination of the dilution expected from Perrigo acquisition and the reversal of […]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.